Evaluating the Risks and Benefits of Phase II and III Cancer Clinical Trials: A Look at Institutional Review Board Members in the Netherlands

A.W. Musschenga; H.E.M. van Luijn; N.K. Aaronson; R.B. Keus

Evaluating the Risks and Benefits of Phase II and III Cancer Clinical Trials: A Look at Institutional Review Board Members in the Netherlands

A.W. Musschenga, H.E.M. van Luijn, N.K. Aaronson, R.B. Keus

Research output: Contribution to Journal › Article › Academic

46 Downloads (Pure)

Original language	English
Pages (from-to)	13-19
Journal	IRB: Ethics and Human Behavior
Volume	2007
Issue number	29
Publication status	Published - 2007

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

Van Luijn et al IRB 2007Final published version, 81.8 KB

Persistent URL (handle)

Persistent link

Cite this

@article{50118395195545b89b030590dfe37a1d,

title = "Evaluating the Risks and Benefits of Phase II and III Cancer Clinical Trials: A Look at Institutional Review Board Members in the Netherlands",

author = "A.W. Musschenga and {van Luijn}, H.E.M. and N.K. Aaronson and R.B. Keus",

year = "2007",

language = "English",

volume = "2007",

pages = "13--19",

journal = "IRB: Ethics and Human Behavior",

issn = "0193-7758",

publisher = "Hastings Center",

number = "29",

}

TY - JOUR

T1 - Evaluating the Risks and Benefits of Phase II and III Cancer Clinical Trials: A Look at Institutional Review Board Members in the Netherlands

AU - Musschenga, A.W.

AU - van Luijn, H.E.M.

AU - Aaronson, N.K.

AU - Keus, R.B.

PY - 2007

Y1 - 2007

M3 - Article

SN - 0193-7758

VL - 2007

SP - 13

EP - 19

JO - IRB: Ethics and Human Behavior

JF - IRB: Ethics and Human Behavior

IS - 29

ER -